Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Diabetes. Nov 15, 2026; 17(11): 124291
Published online Nov 15, 2026. doi: 10.4239/wjd.124291
Published online Nov 15, 2026. doi: 10.4239/wjd.124291
Accuracy and feasibility of initiating real-time continuous glucose monitoring in noncritically ill hospitalized patients with type 2 diabetes
Sirinart Sirinvaravong, Choompunuj Sakjirapapong, Nuntakorn Thongtang, Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Krung Thep Maha Nakhon, Thailand
Sirinart Sirinvaravong, Lukana Preechasuk, Nuntakorn Thongtang, Siriraj Diabetes Center of Excellence, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Krung Thep Maha Nakhon, Thailand
Choompunuj Sakjirapapong, Medicine, Diabetes, Thyroid and Endocrine Center, Phyathai 2 International Hospital, Bangkok 10400, Krung Thep Maha Nakhon, Thailand
Author contributions: Sirinvaravong S, Sakjirapapong C, Preechasuk L, and Thongtang N developed the research design and study protocol, performed patient enrollment and data collection; Sirinvaravong S and Sakjirapapong C performed data analysis and drafted the manuscript; Sirinvaravong S and Thongtang N critically reviewed and revised the manuscript; and all authors have read and approved the submitted version of the manuscript and agree to be individually and collectively responsible for the accuracy of the data.
AI contribution statement: Portions of this manuscript were edited using AI tools solely for language refinement. The authors carefully reviewed and verified all AI-assisted outputs and take full responsibility for the scientific content of the manuscript.
Supported by Specific League Funds, No. R016421005.
Institutional review board statement: The study protocol was approved by the Siriraj Institutional Review Board (COA No. Si 644/2021).
Clinical trial registration statement: The study was retrospectively registered in the Thai Clinical Trials Registry (TCTR20230426007; https://www.thaiclinicaltrials.org/show/TCTR20230426007).
Informed consent statement: All participants provided written informed consent before study enrollment.
Conflict-of-interest statement: All authors declare no commercial, personal, political, intellectual, or religious conflicts of interest relating to any aspect of this study.
CONSORT 2010 statement: The authors have read the CONSORT 2010 Statement, and the manuscript was prepared and revised according to the CONSORT 2010 Statement.
Data sharing statement: The data supporting the findings of this study are available from the corresponding author upon reasonable request.
Corresponding author: Nuntakorn Thongtang, MD, Professor, Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol Uni versity, 2 Wanglang Road, Bangkoknoi, Bangkok 10700, Krung Thep Maha Nakhon, Thailand. nutakorn.thn@mahidol.ac.th
Received: June 15, 2026
Revised: July 25, 2026
Accepted: October 8, 2026
Published online: November 15, 2026
Processing time: 147 Days and 23.9 Hours
Revised: July 25, 2026
Accepted: October 8, 2026
Published online: November 15, 2026
Processing time: 147 Days and 23.9 Hours
Core Tip
Core Tip: Evidence regarding the initiation of real-time continuous glucose monitoring (rt-CGM) in hospitalized adults remains scarce. This study evaluated the accuracy and feasibility of initiating the Glunovo i3 rt-CGM system for inpatient glycemic monitoring among 25 patients with type 2 diabetes mellitus (T2DM) admitted to non-intensive care unit medical wards. Among 397 paired capillary blood glucose and sensor glucose measurements, the mean absolute relative difference was 12.2%, with 96.7% of values falling within zones A and B of the Clarke Error Grid Analysis. These findings suggest that initiating rt-CGM in hospitalized patients with T2DM is feasible and demonstrates acceptable accuracy for glucose monitoring.